Literature DB >> 12003996

Microvessel morphology and vascular endothelial growth factor expression in human colonic carcinoma with or without metastasis.

Tsuyotoshi Tsuji1, Yoshihiro Sasaki, Masanori Tanaka, Norihiro Hanabata, Ryukichi Hada, Akihiro Munakata.   

Abstract

We quantified microvessel morphology and vascular endothelial growth factor (VEGF) expression in human colonic carcinoma with or without metastasis. The cancerous growth and the noncancerous section of surgical specimens from 36 patients with colorectal carcinoma (14 without metastasis and 22 with metastasis) were studied. Tissue slices immunostained with CD34 were processed for microvessel counts (per mm(2)), the mean diameter of microvessels (microm), and the mean spatial direction of microvessels (degree), defined by the angle between the longitudinal axis of microvessels and the direction perpendicular to the surface of the mucosa. Tissue slices immunostained with anti-VEGF antibody were processed for total epithelial cell counts (per mm(2)), VEGF-positive cell counts (per mm(2)), and VEGF-positive ratio (%). Carcinoma without metastasis had significantly larger microvessel counts (213 +/- 77, p < 0.01), larger microvessel diameter (7.99 +/- 1.77, p < 0.05), and larger spatial direction (47.2 +/- 8.3, p < 0.01) than normal tissue (144 +/- 49 for microvessel counts; 7.03 +/- 0.90 for microvessel diameter; 39.5 +/- 6.6 for spatial direction). Compared with carcinoma without metastasis, carcinoma with metastasis had a significantly larger microvessel diameter (9.75 +/- 2.65, p < 0.03) and lower microvessel counts (180 +/- 92, p = 0.51). Carcinoma without metastasis had a significantly larger VEGF-positive cell count (1276 +/- 805, p < 0.05) and larger VEGF-positive ratio (53.6 +/- 39.3, p < 0.05) than normal tissue (571 +/- 553 for VEGF-positive cell counts; 24.6 +/- 23.2 for VEGF-positive ratio). Carcinoma with metastasis had a significantly lower total cell count (1443 +/- 237, p < 0.001) and lower VEGF-positive cell count (716 +/- 463, p < 0.05) than carcinoma without metastasis. With tumor progression, microvessel diameter significantly increased and microvessel counts decreased, which can be in part explained by VEGF expression. The microvessel diameter seems to be the dominant parameter responsible for cancer cell intravasation as the first step of metastasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003996     DOI: 10.1038/labinvest.3780450

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

Authors:  D Wang; C R Stockard; L Harkins; P Lott; C Salih; K Yuan; D Buchsbaum; A Hashim; M Zayzafoon; R W Hardy; O Hameed; W Grizzle; G P Siegal
Journal:  Biotech Histochem       Date:  2008-06       Impact factor: 1.718

2.  Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data.

Authors:  Benjamin Titz; Kevin R Kozak; Robert Jeraj
Journal:  Phys Med Biol       Date:  2012-09-13       Impact factor: 3.609

3.  Erythrocyte protoporphyrin fluorescence as a biomarker for monitoring antiangiogenic cancer therapy.

Authors:  Flávia Gomes de Góes Rocha; Karen Cristina Barbosa Chaves; Cinthia Zanini Gomes; Camila Barricheli Campanharo; Lilia Coronato Courrol; Nestor Schor; Maria Helena Bellini
Journal:  J Fluoresc       Date:  2010-05-18       Impact factor: 2.217

Review 4.  Changes in cellular mechanical properties during onset or progression of colorectal cancer.

Authors:  Gabriele Ciasca; Massimiliano Papi; Eleonora Minelli; Valentina Palmieri; Marco De Spirito
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

5.  VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese.

Authors:  Motohiro Yamamori; Mayuko Taniguchi; Shingo Maeda; Tsutomu Nakamura; Noboru Okamura; Akiko Kuwahara; Koichi Iwaki; Takao Tamura; Nobuo Aoyama; Svetlana Markova; Masato Kasuga; Katsuhiko Okumura; Toshiyuki Sakaeda
Journal:  Int J Med Sci       Date:  2008-04-08       Impact factor: 3.738

6.  Aggressive prostate cancer cell nuclei have reduced stiffness.

Authors:  Zeina S Khan; Julianna M Santos; Fazle Hussain
Journal:  Biomicrofluidics       Date:  2018-01-02       Impact factor: 2.800

7.  Expression of Genes Involved in Porphyrin Biosynthesis Pathway in the Human Renal Cell Carcinoma.

Authors:  Hugo Nóbrega da Rocha Filho; Evelin Caroline da Silva; Flávia R O Silva; Lilia Coronato Courrol; Carlos Henrique de Mesquita; Maria Helena Bellini
Journal:  J Fluoresc       Date:  2015-08-06       Impact factor: 2.217

Review 8.  Tumor cell intravasation.

Authors:  Serena P H Chiang; Ramon M Cabrera; Jeffrey E Segall
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

9.  Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.

Authors:  Bin Xiong; Tao-Jiao Sun; Hong-Yin Yuan; Ming-Bo Hu; Wei-Dong Hu; Fu-Lin Cheng
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

10.  Role of cancer microenvironment in metastasis: focus on colon cancer.

Authors:  Stéphanie Gout; Jacques Huot
Journal:  Cancer Microenviron       Date:  2008-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.